PTC Therapeutics
Lesley-Anne Chapman currently serves as the Manager of Regulatory Submissions Planning at PTC Therapeutics, Inc., a position held since February 2023. Prior experience includes managerial roles in regulatory publishing and operations at Voisin Consulting Life Sciences from September 2021 to February 2023 and as a Principal Submission Consultant at DLRC Regulatory Consultancy from June 2020 to September 2021. Lesley-Anne held the position of Global Regulatory Operations Manager at Celgene and served as Global Submission Manager at PRA Health Sciences before taking a career break to care for a family member from July 2017 to June 2018. Previous significant roles include Associate Director of Submission Sciences and Senior Manager at Biogen, as well as a Senior Consultant at Liquent Ltd. Lesley-Anne's career began at Pfizer, where responsibilities included the role of Senior Associate. Expertise encompasses leading project teams, ensuring the quality and timeliness of regulatory submissions in compliance with agency guidelines.
This person is not in any teams
This person is not in any offices
PTC Therapeutics
11 followers
PTC is a science-driven, patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare disease.